Schall, CA
Edward M. Schall, San Francisco, CA US
Patent application number | Description | Published |
---|---|---|
20110029651 | DYNAMIC SERVER CONSOLIDATION AND RATIONALIZATION MODELING TOOL - A method and system for providing efficient and flexible techniques for modeling technical and economic benefits of consolidating information technology (IT) systems, hardware, software, network, and other infrastructure are described. The system includes a data processing system configured to receive data from a user. The system also includes an input collection system communicatively coupled to the data processing system, with the input collection system designed to organize, convert, and sort the data to generate baseline server information. In addition, the system includes an optimization system communicatively coupled to the data processing system, with the optimization system designed to generate one or more server consolidation models based on the baseline server information. Further, based on the generated one or more server consolidation models, a recommendation can be generated. | 02-03-2011 |
Fran Schall, San Francisco, CA US
Patent application number | Description | Published |
---|---|---|
20100280942 | METHOD AND SYSTEM FOR FACILITATING SWITCHING OF FINANCIAL INSTITUTION ACCOUNTS - Techniques for switching a financial institution account for a debit account holder are provided. A request to convert a financial institution account is received from a customer. Information is obtained from the customer and used to identify a list of possible financial institution candidates. The list of possible financial institution candidates includes financial institutions that have an on-going relationship with an existing payment association and are interested in offering a new financial institution account to the customer. A new financial institution account is then established with a financial institution selected from a list of possible financial institution candidates. Then, the new financial institution account is linked to one or more additional accounts. The one or more additional accounts may be an account with the customer's existing payment association or accounts associated with any recurring transactions. | 11-04-2010 |
20110078075 | METHOD AND SYSTEM FOR FACILITATING SWITCHING OF FINANCIAL INSTITUTION ACCOUNTS - Techniques for switching a financial institution account for a debit account holder are provided. A request to convert a financial institution account is received from a customer. Information is obtained from the customer and used to identify a list of possible financial institution candidates. The list of possible financial institution candidates includes financial institutions that have an on-going relationship with an existing payment association and are interested in offering a new financial institution account to the customer. A new financial institution account is then established with a financial institution selected from a list of possible financial institution candidates. Then, the new financial institution account is linked to one or more additional accounts. The one or more additional accounts may be an account with the customer's existing payment association or accounts associated with any recurring transactions. | 03-31-2011 |
Thomas Schall, Palo Alto, CA US
Patent application number | Description | Published |
---|---|---|
20080261966 | BIS-ARYL SULFONAMIDES - Compounds are provided that act as potent antagonists of chemokine receptors. The compounds are generally aryl sulfonamide derivatives and are useful in pharmaceutical compositions, methods for the treatment of chemokine receptor-mediated diseases, and as controls in assays for the identification of chemokine antagonists. | 10-23-2008 |
20100144720 | INHIBITORS OF HUMAN TUMOR-EXPRESSED CCXCKR2 - Pharmaceutical compositions containing organic compounds or salts thereof that serve as modulators for the SDF-1 or I-TAC chemokines are disclosed. The compounds and compositions are useful in the treatment of cancer, especially in the inhibition of cancer proliferation, growth, and metastasis. Methods of interfering with SDF-1 and/or I-TAC binding to the CCXCKR2 receptor and treating cancer using the compounds and pharmaceutical compositions of the present invention are also disclosed. | 06-10-2010 |
20100227902 | BIS-ARYL SULFONAMIDES - Compounds are provided that act as potent antagonists of chemokine receptors. The compounds are generally aryl sulfonamide derivatives and are useful in pharmaceutical compositions, methods for the treatment of chemokine receptor-mediated diseases, and as controls in assays for the identification of chemokine antagonists. | 09-09-2010 |
20100247540 | Methods and Compositions For Modulating Angiogenesis - The present invention provides method and compositions for modulating angiogenesis. | 09-30-2010 |
20100278820 | REAGENTS THAT BIND CCX-CKR2 - Antibodies that bind to CCX-CKR2 and methods of their use are provided. | 11-04-2010 |
20110257183 | BIS-ARYL SULFONAMIDES - Compounds are provided that act as potent antagonists of chemokine receptors. The compounds are generally aryl sulfonamide derivatives and are useful in pharmaceutical compositions, methods for the treatment of chemokine receptor-mediated diseases, and as controls in assays for the identification of chemokine antagonists. | 10-20-2011 |
Thomas J. Schall, Palo Alto, CA US
Patent application number | Description | Published |
---|---|---|
20090054630 | Compositions and methods for detecting and treating diseases and conditions related to chemokine receptors - Antibodies that bind CCX-CKR2 are described. | 02-26-2009 |
20110052589 | COMPOSITIONS AND METHODS FOR DETECTING AND TREATING DISEASES AND CONDITIONS RELATED TO CHEMOKINE RECEPTORS - Ligands of CCX-CKR2 and the biological role of CCX-CKR2 in cancer is described. | 03-03-2011 |
20110165164 | COMPOSITIONS AND METHODS FOR DETECTING AND TREATING DISEASES AND CONDITIONS RELATED TO CHEMOKINE RECEPTORS - Ligands of CCX-CKR2 and the biological role of CCX-CKR2 in cancer is described. | 07-07-2011 |
Thomas J. Schall, Menlo Park, CA US
Patent application number | Description | Published |
---|---|---|
20090017032 | MAMMALIAN CX3C CHEMOKINE ANTIBODIES - Nucleic acids encoding a new family of chemokines, the CX3C family, from a mammal, reagents related thereto, including specific antibodies, and purified proteins are described. Methods of using said reagents and related diagnostic kits are also provided. | 01-15-2009 |
20090191629 | MAMMALIAN CHEMOKINE REAGENTS - Novel chemokines from mammals, reagents related thereto including purified proteins, specific antibodies, and nucleic acids encoding said chemokines. Chemokine receptors are also provided. Methods of using said reagents and diagnostic kits are also provided. | 07-30-2009 |
20110189123 | MAMMALIAN CX3C CHEMOKINE ANTIBODIES - Nucleic acids encoding a new family of chemokines, the CX3C family, from a mammal, reagents related thereto, including specific antibodies, and purified proteins are described. Methods of using said reagents and related diagnostic kits are also provided. | 08-04-2011 |
Thomas P. Schall, Menlo Park, CA US
Patent application number | Description | Published |
---|---|---|
20090317398 | MAMMALIAN CX3C CHEMOKINE ANTIBODIES - Nucleic acids encoding a new family of chemokines, the CX3C family, from a mammal, reagents related thereto, including specific antibodies, and purified proteins are described. Methods of using said reagents and related diagnostic kits are also provided. | 12-24-2009 |
20120225482 | MAMMALIAN CX3C CHEMOKINE ANTIBODIES - Nucleic acids encoding a new family of chemokines, the CX3C family, from a mammal, reagents related thereto, including specific antibodies, and purified proteins are described. Methods of using said reagents and related diagnostic kits are also provided. | 09-06-2012 |